Understanding the Role of Risperidone and Aripiprazole in Treating Symptoms of ASD

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterized by social communication challenges and restricted, repetitive patterns of behavior. Research suggests that individuals with ASD may also experience co-occurring behavioral issues such as irritability, aggression, and mood dysregulation. In recent years, pharmacological interventions have become an integral part of the management strategy for addressing these associated symptoms. Among these, two atypical antipsychotic medications, risperidone and aripiprazole, have garnered significant attention from practitioners and researchers. This article explores the efficacy, safety, and considerations of using these medications for individuals with ASD. #### Overview of Risperidone Risperidone is an atypical antipsychotic that has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of irritability associated with ASD in children and adolescents aged 5 to 16 years. It works by m...